For patients with Parkinson's Disease
Where will they
XADAGO NEXT?
XADAGO, an adjunct
to levodopa, improves on time–without troublesome dyskinesia1
learn more
The limitations
of Levodopa2,3
Extending symptom control,
expanding the possibilities
Find out more
Xadago efficacy1
Improvements in on time without troublesome dyskinesia, off time, and motor function
View the data
Who can Xadago help?
Identifying the right patients for once-daily Xadago
Click here
References
- XADAGO® (safinamide) [Prescribing Information]. Louisville, KY: US WorldMeds, LLC; 2017.
-
Hickey P, Stacy M. Available and emerging treatments for Parkinson’s
disease: a review. Drug Des Devel Ther. 2011:241-254.
-
Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s
disease: clinical manifestations. Mov Disord.2005;20(11):S11-S16.